Inflammation is associated with diverse clinical conditions accompanied by characteristic changes in serum levels of the acutephase proteins that can be used to stage the inflammatory process and evaluate the impact of treatment. Some acute-phase proteins increase during inflammation, while others,
Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort
✍ Scribed by Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas B. Ledue; Wendy Y. Craig
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 170 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0887-8013
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The principal considerations driving iron status evaluation are clinical concern for anemia and the possibility of iron‐storage disease. Most often, the circulating levels of transferrin (or total iron binding capacity) and serum iron are measured and the percentage of transferrin saturation (TSAT) is then computed. Optimally, reference ranges for these analytes should exclude the effects of the acute phase response, nutritional status, estrogen effect, specific genetic disorders, liver disease, and blood transfusion. The current study reports reference ranges for serum iron and TSAT within a cohort of over 55,000 Caucasians from northern New England, tested in our laboratory between 1994 and 1999. Measurements were standardized against serum reference material (SRM) 937 (for iron) and certified reference material (CRM) 470 (also called reference preparation for proteins in human serum (RPPHS)) (for transferrin), and analyzed using a previously published approach. Individual cases with evidence of inflammation (C‐reactive protein ≥10 mg/L), or iron overload (TSAT >80% for males and >70% for females) or serum iron values <5 μmol/L, were removed. Among the referent individuals, iron and TSAT levels rose slightly until the teen years, at which time levels in males increased while those in females remained essentially constant. Between 20 and 70 years of age, males had 10–15% higher iron levels and 15–20% higher TSAT levels than females. When values were expressed as multiples of the age‐ and gender‐specific median levels, the serum iron and TSAT observations fit log‐Gaussian distributions reasonably well from the 20th to 99th centile, and the 10th to the 99th centile, respectively. After normalization, the Gaussian parameters can be used to assign a corresponding centile to an individual's measurement, simplifying interpretation. These data provide new and more detailed reference ranges for serum iron and TSAT. J. Clin. Lab. Anal. 16:237–245, 2002. © 2002 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract In this 11th article in a series, reference values of serum levels alpha~2~‐macroglobulin α~2~M) are examined. The study is based on a cohort of 40,420 Caucasian individuals from northern New England that were tested in our laboratory between 1994 and 2000. Measurements were standardize
Serum immunoglobulins are measured millions of times each year, yet clinical interpretations remain hampered by inadequate age- and gender-specific reference limits. In order to provide more reliable and comprehensive reference distributions for IgA, IgG, and IgM measurements, we analyzed automated
## Abstract The two serum proteins of the complement cascade in the highest concentrations, C3 and C4, respond to various conditions in much the same manner as do other positive acute‐phase proteins. A major difference is that they are relatively sluggish in response to cytokine drive, requiring se
## Abstract The appropriate clinical use of serum iron and transferrin saturation (TSAT) requires satisfactory reference intervals from birth to old age, and for males and females. This study identified 54 publications from 1974 to 2001 that met the criteria used in three prior meta‐analyses, and t
## Abstract The two serum apolipoproteins in the highest concentrations, apolipoprotein (apo) AI and apolipoprotein B, and the apolipoprotein B/AI ratio are measured to assess clinical risk for atherosclerotic heart and peripheral vascular diseases. The study is based on a cohort of over 37,000 Cau